Baxter International (NYSE:BAX) Price Target Raised to $40.00 at Citigroup
Baxter International (NYSE:BAX – Free Report) had its price objective lifted by Citigroup from $38.00 to $40.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock. A number of other equities research analysts have also issued reports on the company. JPMorgan Chase […]
5 Oct 22:05 · The Markets Daily